● Breaking · April 2026
11 min read
FDA Schedules July 23–24 PCAC Meeting on 7 Peptides
The FDA has opened public comment on BPC-157, TB-500, and five other peptides for Section 503A bulk drug substances. Analysis of what compounding pharmacies, clinicians, and patients need to know before the July comment deadline.
Read analysis →